King, M. L., Lindberg, M. E., Stodden, G. R., Okuda, H., Ebers, S. D., Johnson, A., . . . Hayashi, K. (2014). WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer. Oncogene.
Chicago Style CitationKing, Mandy L., et al. "WNT7A/β-catenin Signaling Induces FGF1 and Influences Sensitivity to Niclosamide in Ovarian Cancer." Oncogene 2014.
Cita MLAKing, Mandy L., et al. "WNT7A/β-catenin Signaling Induces FGF1 and Influences Sensitivity to Niclosamide in Ovarian Cancer." Oncogene 2014.
Atenció: Aquestes cites poden no estar 100% correctes.